SolasCure Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Investors
-
16
SolasCure General Information
Description
Developer of a wound care therapy designed to treat chronic wounds and support faster healing. The company offers biologic wound gel with continuous debridement and tissue repair activation features, enabling healthcare providers and patients to improve wound management and recovery outcomes.
Contact Information
Website
www.solascure.comCorporate Office
- Wellington House
- East Road
- Cambridge CB1 1BH
- England, United Kingdom
Corporate Office
- Wellington House
- East Road
- Cambridge CB1 1BH
- England, United Kingdom
SolasCure Timeline
SolasCure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Apr-2025 | Completed | Clinical Trials - Phase 2 | |||
| 6. Accelerator/Incubator | 03-Jun-2024 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 20-Mar-2024 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 21-Jun-2023 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC (Series B) | 27-Mar-2023 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 31-Jan-2021 | $21M | $21M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC | 01-Jan-2018 | Completed | Startup |
SolasCure Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | 257,445,314 | $0.013639 | $0.03 | $0.03 | 1x | $0.03 | 11.82% | |
| Preference | 278,246,000 | $0.013639 | $0.03 | $0.03 | 1x | $0.03 | 12.77% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SolasCure Comparisons
Industry
Financing
Details
SolasCure Competitors (3)
One of SolasCure’s 3 competitors is Biotherapy Services, a Private Equity-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biotherapy Services | Private Equity-Backed | London, United Kingdom | ||||
| MediWound | Formerly PE-Backed | Yavne, Israel | ||||
| Smith & Nephew (medical devices) | Corporation |
SolasCure Signals
SolasCure Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Texas Medical Center | Venture Capital | Minority | ||
| Innovate UK | Government | |||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Meltwind Advisory | Venture Capital | Minority | ||
| Wealth Club | Corporation | Minority |
SolasCure FAQs
-
When was SolasCure founded?
SolasCure was founded in 2017.
-
Where is SolasCure headquartered?
SolasCure is headquartered in Cambridge, United Kingdom.
-
What is the size of SolasCure?
SolasCure has 11 total employees.
-
What industry is SolasCure in?
SolasCure’s primary industry is Drug Discovery.
-
Is SolasCure a private or public company?
SolasCure is a Private company.
-
What is SolasCure’s current revenue?
The current revenue for SolasCure is .
-
How much funding has SolasCure raised over time?
SolasCure has raised $34.2M.
-
Who are SolasCure’s investors?
Texas Medical Center, Innovate UK, European Innovation Council, Meltwind Advisory, and Wealth Club are 5 of 16 investors who have invested in SolasCure.
-
Who are SolasCure’s competitors?
Biotherapy Services, MediWound, and Smith & Nephew (medical devices) are competitors of SolasCure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process